Page last updated: 2024-10-29

iohexol and B16 Melanoma

iohexol has been researched along with B16 Melanoma in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finger, PT1
Ho, TK1
Fastenberg, DM1
Hyman, RA1
Stroh, EM1
Packer, S1
Perry, HD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Prospective Pilot Study of Surgical Radiation Shielding With Vitrectomy & Silicone Oil Tamponade for the Protection of Radiation-induced Ocular Injury in the Treatment of Choroidal Melanoma With Radioactive Iodine-125 Plaque Brachytherapy[NCT01460810]20 participants (Actual)Interventional2011-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for iohexol and B16 Melanoma

ArticleYear
Intraocular radiation blocking.
    Investigative ophthalmology & visual science, 1990, Volume: 31, Issue:9

    Topics: Animals; Brachytherapy; Contrast Media; Densitometry; Eye; Eye Neoplasms; Iodine Radioisotopes; Iohe

1990